Cartalax
Content:
30mg/vial x 1
Description
Cartalax is a synthetic tripeptide bioregulator composed of alanine, glutamic acid, and aspartic acid (AED sequence). Developed by the St. Petersburg Institute of Bioregulation and Gerontology, it is designed to support cartilage health, connective tissue integrity, and long-term joint function. The AED sequence matches a fragment of the alpha-1 chain of type XI collagen, a key structural protein that maintains cartilage integrity and extracellular matrix organization.
Cartalax supports the body's natural regenerative mechanisms that maintain healthy cartilage and connective tissue. It has shown efficacy in promoting chondrocyte proliferation, supporting cartilage matrix formation, and reducing markers of cellular senescence. Research suggests it may help regulate normal inflammatory responses associated with physical stress and intensive exercise. Clinical studies have demonstrated effectiveness in supporting reparative osteogenesis in older age groups. By encouraging healthy tissue regeneration and maintaining joint integrity, Cartalax may help improve flexibility, mobility, and resilience while supporting recovery following repetitive mechanical loading and demanding athletic activity.
Benefits
-
Supports Cartilage Health
Stimulates chondrocyte proliferation and promotes cartilage matrix formation. -
Promotes Joint Mobility
Helps maintain flexibility and joint function. -
Supports Connective Tissue Integrity
Aids in maintaining healthy tendons, ligaments, and cartilage. -
Reduces Cellular Senescence Markers
May reduce expression of p16, p21, and p53 associated with cellular aging. -
Supports Bone Health
May influence calcium metabolism through thyroid C cells. -
Recovery from Joint Stress
Supports recovery from repetitive mechanical loading. -
Long-Term Musculoskeletal Wellness
Helps maintain active performance and mobility. -
Supports Heavy Training Recovery
Beneficial for athletes and bodybuilders with high joint stress.
Usage & Dosage Guidelines
Recommended dosage: 2 mg per day administered subcutaneously is commonly reported.
Cycle duration: Typically 30–45 days. Courses may be repeated after 4–6 months.
For oral/sublingual use: 10 drops under the tongue twice daily, or 1–2 capsules 1–2 times daily with meals, typically for 10–30 days.
Storage: Store lyophilized vials at 2–8°C, protected from direct sunlight. After reconstitution, refrigerate immediately, avoid freezing, and maintain proper aseptic handling.
Cycle Support
Regular monitoring of joint health and overall musculoskeletal function may be recommended during prolonged treatment. Maintain proper hydration and a nutrient-dense diet to support cartilage and connective tissue health.
Stacking
Cartalax is commonly incorporated into joint support and regenerative protocols. It may be used alongside recovery peptides such as BPC-157 and TB-500, growth hormone secretagogues, or other connective tissue support compounds under appropriate professional supervision. Combination protocols should always be individualized according to injury status, recovery requirements, and performance goals.
Contraindications
Do not use Cartalax if you have known hypersensitivity to any peptide components, active malignancy or tumor growth (theoretical concern due to senescence marker modulation), autoimmune or connective tissue diseases, or during pregnancy and breastfeeding.
Special Precautions
Use only under professional medical supervision. Individuals with chronic musculoskeletal disorders, autoimmune conditions, connective tissue diseases, or those who are pregnant or breastfeeding should consult a healthcare provider before use. All safety data originates from Khavinson's research group with no formal toxicology studies meeting regulatory standards. Long-term safety data is limited. The theoretical risk of oncogenicity exists due to senescence marker suppression.
Adverse Drug Reactions
Cartalax is generally well tolerated in available preclinical studies, with no adverse effects reported. Some individuals may experience mild injection-site discomfort, temporary fatigue, or headache. Allergic reactions are uncommon but remain possible with any injectable peptide. If severe or persistent adverse effects occur, discontinue use and consult a healthcare professional.
Drug Interactions
Limited data available. Use with caution alongside other medications affecting cartilage or bone metabolism. No formal drug interaction studies have been conducted.
Frequently Asked Questions (FAQs)
1. What is Cartalax used for?
Cartalax is used to support cartilage health, joint mobility, connective tissue integrity, and recovery from repetitive joint stress and intense physical training.
2. How does Cartalax work?
It supports chondrocyte proliferation, promotes cartilage matrix formation, reduces cellular senescence markers (p16, p21, p53), and may influence calcium metabolism.
3. How do I take Cartalax?
Dosage should be individualized under professional supervision. Reported protocols include 2 mg daily subcutaneously. Oral/sublingual forms are also available.
4. How should I store Cartalax?
Store lyophilized vials at 2–8°C, protected from direct sunlight. After reconstitution, refrigerate immediately and avoid freezing.
5. Can Cartalax be stacked with other products?
Yes, it may be used alongside recovery peptides like BPC-157 and TB-500, growth hormone secretagogues, or other connective tissue support compounds.
6. What are the common side effects?
No adverse effects have been reported in preclinical studies. Mild injection-site discomfort or fatigue may occasionally occur.
7. Who should not use Cartalax?
Do not use if you have hypersensitivity to peptide components, active malignancy, autoimmune conditions, or during pregnancy and breastfeeding.
8. Is Cartalax safe for long-term use?
Long-term safety data is limited. All safety data originates from Khavinson's research group with no formal toxicology studies meeting regulatory standards.
9. Does Cartalax help with osteoarthritis?
Research suggests Cartalax may support cartilage health and has shown efficacy in animal models of osteoarthritis.
10. Do I need post-cycle therapy (PCT) after using Cartalax?
Cartalax does not suppress natural hormones, so PCT is not required. Professional medical supervision is still recommended.
Disclaimer
The information provided is for educational purposes only and is not intended as medical advice. Cartalax should only be used under the supervision of a qualified healthcare professional. This product is not intended to diagnose, treat, cure, or prevent any disease. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.
🛡️ Cartalax — Support Cartilage Health, Joint Function, Connective Tissue Integrity & Long-Term Musculoskeletal Wellness
